Market Overview:
The global athlete's foot drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of athlete's foot, rising awareness about the available treatment options, and growing demand for over-the-counter (OTC) drugs. The global athlete's foot drugs market is segmented on the basis of type into creams, sprays, and others. The creams segment is expected to account for a major share of the global athlete's foot drugs market in 2018 owing to their high efficacy and ease of use. On the basis of application, the hospital pharmacy segment is expected to account for a major share of the global athlete's foot drugs market in 2018 owing to increased prevalence of Athlete’s Foot infections in hospitals across regions.
Product Definition:
Athlete's foot is a fungal infection of the feet. Athlete's foot drugs are medications used to treat or prevent athlete's foot. These drugs may be over-the-counter (OTC) or prescription medications.
Cream:
Cream is a topical drug used for the treatment of athlete's foot. It works by killing the bacteria that causes infections and inflammation. The drug also reduces pain, redness, swelling & itching caused by athlete’s foot. Creams are available as over-the-counter (OTC) medications or prescription medications which are used in higher concentrations for treating severe cases of infection and inflammation associated with athletes' foot.
The U.S., Canada, Australia, U.
Spray:
Spray is a topical solution used for treating athlete's foot. It contains urea, which helps in breaking down the keratin that builds a protective layer over the skin and prevents it from drying out. The solution also contains alcohol, which acts as an antiseptic and disinfectant to prevent infection.
Application Insights:
The market is segmented by application into hospital pharmacy, retail pharmacy, and online pharmacy. The online pharmacies dominated the overall industry in terms of revenue share in 2017. This can be attributed to factors such as increasing internet users globally and growing preference for purchasing medicines via the web instead of visiting a local pharmacist or medical storeroom.
The hospital pharmacies are anticipated to register the fastest CAGR over the forecast period owing to rising awareness about foot problems among athletes across various countries including India, China, Australia and New Zealand. Furthermore, an increase in number of hospitals & health care centers coupled with rising prevalence of diseases like diabetes will boost product demand from 2018 to 2030. In addition, increasing spending power along with high living standards have resulted in increased incidence rate for several chronic diseases including heart disease & stroke which will further drive demand over the forecast period (2018-2030).
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and high adoption rate for new treatment options are some factors responsible for its growth. Moreover, increasing incidence of athletes foot among children is also expected to contribute towards regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising healthcare expenditure by governments and private sectors coupled with growing awareness about various treatment options available for Athlete's Foot infection in this region. Increasing number of retail pharmacies due to easy availability of drugs at cheaper rates will also support regional growth during the estimated time span.
Growth Factors:
- Increasing awareness about the health benefits of Athlete's Foot Drugs among consumers.
- Rising demand for natural and organic Athlete's Foot Drugs products.
- Growing number of product launches by key players in the market.
- Increasing adoption of Athlete's Foot Drugs by athletes and sportspersons for better performance and improved recovery time after strenuous physical activity sessions or competitions .
Scope Of The Report
Report Attributes
Report Details
Report Title
Athlete's Foot Drugs Market Research Report
By Type
Cream, Spray, Others
By Application
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Companies
Bayer, GSK, Janssen Pharmaceutica NV, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Athlete's Foot Drugs Market Report Segments:
The global Athlete's Foot Drugs market is segmented on the basis of:
Types
Cream, Spray, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- GSK
- Janssen Pharmaceutica NV
- Bayer
Highlights of The Athlete's Foot Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cream
- Spray
- Others
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Athlete's Foot Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Athlete's foot drugs are medications used to treat athlete's foot. These drugs can be prescribed by a doctor, and they may include topical creams, oral antibiotics, or both.
Some of the major companies in the athlete's foot drugs market are Bayer, GSK, Janssen Pharmaceutica NV, Bayer.
The athlete's foot drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Athlete's Foot Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Athlete's Foot Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Athlete's Foot Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Athlete's Foot Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Athlete's Foot Drugs Market Size & Forecast, 2018-2028
4.5.1 Athlete's Foot Drugs Market Size and Y-o-Y Growth
4.5.2 Athlete's Foot Drugs Market Absolute $ Opportunity
Chapter 5 Global Athlete's Foot Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Athlete's Foot Drugs Market Size Forecast by Type
5.2.1 Cream
5.2.2 Spray
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Athlete's Foot Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Athlete's Foot Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Athlete's Foot Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Athlete's Foot Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Athlete's Foot Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Athlete's Foot Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Athlete's Foot Drugs Market Size Forecast by Type
9.6.1 Cream
9.6.2 Spray
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Athlete's Foot Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Athlete's Foot Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Athlete's Foot Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Athlete's Foot Drugs Market Size Forecast by Type
10.6.1 Cream
10.6.2 Spray
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Athlete's Foot Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Athlete's Foot Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Athlete's Foot Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Athlete's Foot Drugs Market Size Forecast by Type
11.6.1 Cream
11.6.2 Spray
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Athlete's Foot Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Athlete's Foot Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Athlete's Foot Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Athlete's Foot Drugs Market Size Forecast by Type
12.6.1 Cream
12.6.2 Spray
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Athlete's Foot Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Athlete's Foot Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Athlete's Foot Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Athlete's Foot Drugs Market Size Forecast by Type
13.6.1 Cream
13.6.2 Spray
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Athlete's Foot Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Athlete's Foot Drugs Market: Competitive Dashboard
14.2 Global Athlete's Foot Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 GSK
14.3.3 Janssen Pharmaceutica NV
14.3.4 Bayer
